Ocugen, Inc. (OCGN)

Ocugen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	39.46	77.56	95.11	24.19	7.6
Short-Term Investments	0	13.37	0	0	0
Cash & Cash Equivalents	39.46	90.93	95.11	24.19	7.6
Cash Growth	-56.60%	-4.39%	293.17%	218.50%	327.02%
Other Current Assets	3.51	7.56	7.54	1.69	8.17
Total Current Assets	42.97	98.49	102.65	25.88	15.77
Property, Plant & Equipment	17.29	6.05	1.16	0.63	0.22
Other Long-Term Assets	4.29	4.09	1.95	0.87	0.82
Total Long-Term Assets	21.58	10.14	3.12	1.5	1.04
Total Assets	64.55	108.63	105.76	27.38	16.81
Accounts Payable	3.17	8.06	2.31	0.4	1.9
Current Debt	0.57	0.5	0.36	0.28	0.17
Other Current Liabilities	13.34	19.97	4.33	2.94	2.48
Total Current Liabilities	17.09	28.53	7	3.61	4.54
Long-Term Debt	6.37	5.88	2.94	2.21	1.24
Other Long-Term Liabilities	0.53	0.24	0	0	0.01
Total Long-Term Liabilities	6.89	6.12	2.94	2.21	1.25
Total Liabilities	23.98	34.65	9.94	5.83	5.79
Total Debt	6.94	6.37	3.31	2.49	1.41
Debt Growth	8.90%	92.80%	32.77%	76.89%	-83.44%
Retained Earnings	-286.17	-223.09	-131.67	-73.3	-51.48
Comprehensive Income	0.02	0.03	0	0	0
Shareholders' Equity	40.56	73.98	95.82	21.55	11.02
Net Cash / Debt	32.52	84.56	91.8	21.7	6.19
Net Cash / Debt Growth	-61.54%	-7.89%	323.06%	250.71%	-
Net Cash Per Share	0.13	0.39	0.47	0.19	0.45
Working Capital	25.88	69.96	95.65	22.26	11.22
Book Value Per Share	0.17	0.34	0.49	0.19	0.79

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).